Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$18.82 USD
+0.13 (0.70%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $18.83 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-1.13 | 0.00% |
Earnings Summary
For their last quarter, Syndax Pharmaceuticals (SNDX) reported earnings of -$0.80 per share, beating the Zacks Consensus Estimate of $-0.91 per share. This reflects a positive earnings surprise of 12.09%. Look out for SNDX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$1.13 per share, reflecting a year-over-year decrease of 54.79%.
Earnings History
Price & Consensus
Zacks News for SNDX
Incyte (INCY) Announces Data on Monjuvi, FDA Approval for GVHD Drug
SNDX: What are Zacks experts saying now?
Zacks Private Portfolio Services